More than 200,000 patients in Michigan could lose in-network access to Michigan Medicine if a contract dispute with Blue Cross Blue Shield of Michigan is not resolved by 30 June. The standoff centres on payment rates, with Michigan Medicine seeking increases to cover rising costs, while the insurer argues the demands would make coverage unaffordable.
Michigan Medicine reports that its costs have risen by 30 per cent overall and 45 per cent for drugs since before the pandemic, but payment rates have not kept pace. Scott Flanders, chief clinical strategy officer, said the hospital needs a contract that reflects these increases to continue delivering high-quality care.
Blue Cross Blue Shield of Michigan vice president Andy Hetzel stated that the hospital system wants “too much money” and that the insurer must ensure affordability for members. He confirmed that negotiations are ongoing, with regular meetings and teams working to reach an agreement before the deadline.
Patients like Wendy Dwyer, who receives treatment for a chronic heart condition, and Alaina Sullivan, who has heart conditions, expressed anxiety about potentially losing their current providers. Sullivan said her doctor promised to help her get her life back, and she does not want to switch.
If no deal is reached, patients with certain conditions—including pregnancy, cancer, transplant care, terminal illness, and serious acute or chronic illnesses—will have coverage extended for 90 days after 1 July. Michigan Medicine has assured patients it is continuing negotiations to protect all patients’ in-network access in the long term.
